Drug recall · October 4, 2023
Florbetaben F-18 recall
Why: Lack of Assurance of Sterility: out-of-specification test results observed for Filter Integrity Test (FIT).
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Florbetaben F-18 (Neuraceq¿) Injection Solution 1.4 to 135 mCi/mL, 50 mL in 1 multi-dose glass vial, Diagnostic-For Intravenous Use Only, Manufactured by SOFIE Co dba SOFIE, Dulles, VA 20166 for Life Molecular Imagining Ltd., NDC 54828-001-50
- Lots / codes
Batch # FBBVA123082201, EOS: 22 Aug 2023/08:25, EXP: 22 Aug 2023/18:25
- Quantity
- 6 patient doses
- Company
- Sofie Co dba Sofie, Sterling, VA
- Distribution
- Product was released to one facility in VA.
- Initiated
- August 22, 2023 · Voluntary: Firm initiated
- Classified
- September 26, 2023
- Reported
- October 4, 2023
- Ended
- December 4, 2023
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.